BIOG
NEUTRALBioMarin Pharmaceuticals to acquire BIOG portfolio company, Amicus Therapeutics
The biotechnology company has announced the acquisition of one of its portfolio companies by a larger pharmaceutical firm.
Biotech Growth
1,190.00GBX
1.28%
Market Cap
252.24M
Volume
31.07k
37% of avg
P/E Ratio
NaN
EPS (TTM)
N/A
Beta
N/A
Day Range
1,165.00p - 1,195.00p
52 Week Range
612.70p1,190.00p1,384.18p
1,190.00p
Upcoming Events
2028
One-off continuation vote
High Impact Event
BIOG
NEUTRALThe Biotech Growth Trust PLC Publishes Monthly Fact Sheet
The prominent investment trust has released its monthly fact sheet, providing an update on its portfolio and performance.
BIOG
NEUTRALThe Biotech Growth Trust PLC Announces Director Appointment
The asset manager has announced the appointment of a non-executive director to the board of another company, effective January 1, 2026.
BIOG
GOODBiotech Growth Trust Reports Strong Half-Year Performance with 36.9% NAV Return
This investment trust reported a stellar 36.9% NAV return, outperforming its benchmark. Strong stock selection and increased gearing contributed to the impressive results, positioning the fund well for future growth in the dynamic biotech sector.
BIOG
NEUTRALThe Biotech Growth Trust PLC Releases Monthly Fact Sheet
The asset management firm has published its monthly fact sheet for The Biotech Growth Trust PLC.
BIOG
NEUTRALThe Biotech Growth Trust PLC Confirms Compliance with Market Abuse Regulation
The investment trust confirms it has complied with market abuse regulations, providing no material updates on its financial position or outlook.
BIOG
NEUTRALThe Biotech Growth Trust PLC Announces Director/PDMR Shareholding
The prominent investment trust has announced a change in its non-executive director's shareholding.
BIOG
NEUTRALThe Biotech Growth Trust PLC Announces Investor Presentation
The prominent investment trust is hosting an investor presentation via Investor Meet Company.
BIOG
NEUTRALThe Biotech Growth Trust PLC Publishes Monthly Fact Sheet
The asset management firm has released its monthly fact sheet, providing an update on the performance of its biotechnology-focused investment trust.
BIOG
BADThe Biotech Growth Trust Provides Investor Webinar Update
The prominent biotech investment trust announces an investor webinar, but the tone of the update suggests the company is facing a challenging operating environment.